Review

.2015 Sep;110(9):1388-403.

doi: 10.1111/add.12998.

Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development

Robert West¹, Martin Raw², Ann McNeill³, Lindsay Stead⁴, Paul Aveyard⁵, John Bitton⁶, John Stapleton⁷, Hayden McRobbie⁸, Subhash Pokhrel⁹, Adam Lester-George¹⁰, Ron Borland¹¹

Affiliations

¹ Cancer Research UK Health Behaviour Research Centre, University College London, London, UK.
² Special Lecturer, UK Centre for Tobacco and Alcohol Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.
³ Professor of Tobacco Addiction, King's College London, UK Centre for Tobacco and Alcohol Studies, National Addiction Centre, London, UK.
⁴ Cochrane Tobacco Addiction Group, Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
⁵ Professor of Behavioural Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK.
⁶ Professor of Epidemiology, UK Centre for Tobacco and Alcohol Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.
⁷ Reader in Addiction Statistical Analysis, Addictions Department, Institute of Psychiatry, Kings College London, London, UK.
⁸ Reader in Public Health Interventions, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
⁹ Health Economics Research Group, Brunel University London, Uxbridge, UK.
¹⁰ LeLan Ltd, Bristol, UK.
¹¹ Cancer Council Victoria, Melbourne, Victoria, Australia.

PMID:26031929
PMCID: PMC4737108
DOI: 10.1111/add.12998

Review

Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development

Robert West et al. Addiction.2015 Sep.

.2015 Sep;110(9):1388-403.

doi: 10.1111/add.12998.

Authors

Robert West¹, Martin Raw², Ann McNeill³, Lindsay Stead⁴, Paul Aveyard⁵, John Bitton⁶, John Stapleton⁷, Hayden McRobbie⁸, Subhash Pokhrel⁹, Adam Lester-George¹⁰, Ron Borland¹¹

Affiliations

¹ Cancer Research UK Health Behaviour Research Centre, University College London, London, UK.
² Special Lecturer, UK Centre for Tobacco and Alcohol Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.
³ Professor of Tobacco Addiction, King's College London, UK Centre for Tobacco and Alcohol Studies, National Addiction Centre, London, UK.
⁴ Cochrane Tobacco Addiction Group, Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
⁵ Professor of Behavioural Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, UK.
⁶ Professor of Epidemiology, UK Centre for Tobacco and Alcohol Studies, Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK.
⁷ Reader in Addiction Statistical Analysis, Addictions Department, Institute of Psychiatry, Kings College London, London, UK.
⁸ Reader in Public Health Interventions, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
⁹ Health Economics Research Group, Brunel University London, Uxbridge, UK.
¹⁰ LeLan Ltd, Bristol, UK.
¹¹ Cancer Council Victoria, Melbourne, Victoria, Australia.

PMID:26031929
PMCID: PMC4737108
DOI: 10.1111/add.12998

Abstract

Aims: This paper provides a concise review of the efficacy, effectiveness and affordability of health-care interventions to promote and assist tobacco cessation, in order to inform national guideline development and assist countries in planning their provision of tobacco cessation support.

Methods: Cochrane reviews of randomized controlled trials (RCTs) of major health-care tobacco cessation interventions were used to derive efficacy estimates in terms of percentage-point increases relative to comparison conditions in 6-12-month continuous abstinence rates. This was combined with analysis and evidence from 'real world' studies to form a judgement on the probable effectiveness of each intervention in different settings. The affordability of each intervention was assessed for exemplar countries in each World Bank income category (low, lower middle, upper middle, high). Based on World Health Organization (WHO) criteria, an intervention was judged as affordable for a given income category if the estimated extra cost of saving a life-year was less than or equal to the per-capita gross domestic product for that category of country.

Results: Brief advice from a health-care worker given opportunistically to smokers attending health-care services can promote smoking cessation, and is affordable for countries in all World Bank income categories (i.e. globally). Proactive telephone support, automated text messaging programmes and printed self-help materials can assist smokers wanting help with a quit attempt and are affordable globally. Multi-session, face-to-face behavioural support can increase quit success for cigarettes and smokeless tobacco and is affordable in middle- and high-income countries. Nicotine replacement therapy, bupropion, nortriptyline, varenicline and cytisine can all aid quitting smoking when given with at least some behavioural support; of these, cytisine and nortriptyline are affordable globally.

Conclusions: Brief advice from a health-care worker, telephone helplines, automated text messaging, printed self-help materials, cytisine and nortriptyline are globally affordable health-care interventions to promote and assist smoking cessation. Evidence on smokeless tobacco cessation suggests that face-to-face behavioural support and varenicline can promote cessation.

Keywords: Affordability; NRT; behavioural support; brief interventions; cytisine; effectiveness; efficacy; interventions; smoking cessation; tobacco cessation.

PubMed Disclaimer

Cited by

Global tobacco prevention and control in relation to a cardiovascular health promotion and disease prevention framework: A narrative review.
Carroll AJ, Labarthe DR, Huffman MD, Hitsman B.Carroll AJ, et al.Prev Med. 2016 Dec;93:189-197. doi: 10.1016/j.ypmed.2016.10.004. Epub 2016 Oct 4.Prev Med. 2016.PMID:27717667Free PMC article.Review.
Most Current Smokers Desire Genetic Susceptibility Testing and Genetically-Efficacious Medication.
Chiu A, Hartz S, Smock N, Chen J, Qazi A, Onyeador J, Ramsey AT, Bierut LJ, Chen LS.Chiu A, et al.J Neuroimmune Pharmacol. 2018 Dec;13(4):430-437. doi: 10.1007/s11481-018-9818-1. Epub 2018 Oct 29.J Neuroimmune Pharmacol. 2018.PMID:30370503Free PMC article.Clinical Trial.
Health Professionals' Counseling about Electronic Cigarettes for Smokers and Vapers in a Country That Bans the Sales and Marketing of Electronic Cigarettes.
Gallegos-Carrillo K, Barrientos-Gutiérrez I, Arillo-Santillán E, Zavala-Arciniega L, Cho YJ, Thrasher JF.Gallegos-Carrillo K, et al.Int J Environ Res Public Health. 2020 Jan 9;17(2):442. doi: 10.3390/ijerph17020442.Int J Environ Res Public Health. 2020.PMID:31936477Free PMC article.
Global and local perspectives on tobacco harm reduction: what are the issues and where do we go from here?
Cox S, Dawkins L.Cox S, et al.Harm Reduct J. 2018 Jun 22;15(1):32. doi: 10.1186/s12954-018-0239-5.Harm Reduct J. 2018.PMID:29933744Free PMC article.No abstract available.
Effectiveness of nicotine replacement therapy sample at outdoor smoking hotspots for initiating quit attempts and use of smoking cessation services: a protocol for a cluster randomised controlled trial.
Cheung YTD, Chan CHH, Ho KS, Tang C, Lau CWH, Li WHC, Wang MP, Lam TH.Cheung YTD, et al.BMJ Open. 2020 Apr 7;10(4):e036339. doi: 10.1136/bmjopen-2019-036339.BMJ Open. 2020.PMID:32269028Free PMC article.

See all "Cited by" articles

References

1. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004; 328: 1519. - PMC - PubMed
1. Pirie K., Peto R., Reeves G. K., Green J., Beral V., Collaborators M. W. S. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 2013; 381: 133–41. - PMC - PubMed
1. Ebbert J., Montori Victor M., Erwin Patricia J., Stead L. F. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev [internet]. 2011; (2). Available at:http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD00430... (accesed June 25 2015). - PubMed
1. West R. The clinical significance of ‘small'effects of smoking cessation treatments. Addiction 2007; 102: 506–9. - PubMed
1. All Party Parliamentary Group on Smoking and Health. Inquiry into the effectiveness and cost‐effectiveness of tobacco control. London: Action on Smoking and Health; 2010.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Movatterモバイル変換

Account

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Full text links

Actions

Share

Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development

Affiliations

Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical